Understanding Disease Progression
IgA nephropathy is the most prevalent primary glomerular disease and a majority of patients will experience kidney failure in their lifetime.1,2 Learn more about current research and best practices in diagnosis and management aimed at improving outcomes in patients.
Understanding Treatment Guidelines
Understand how guidelines are formulated and best
used in clinical practice
PLAY
used in clinical practice
A Pathologist’s Perspective on IgA
Nephropathy
From common features, to challenging histopathology,
renal biopsy is key to diagnosing IgA nephropathy
PLAY
renal biopsy is key to diagnosing IgA nephropathy
Considerations in Management of
IgA Nephropathy
Review and learn more about changing perceptions
around the management of IgA Nephropathy
PLAY
around the management of IgA Nephropathy
Overview of the RaDaR Registry and
Implications of IgA Nephropathy Management
Learn about the recent data from the RaDar Registry and the
potential impact they will have on IgA Nephropathy
management
PLAY
potential impact they will have on IgA Nephropathy
management
Translational Value of Proteinuria and
eGFR as Surrogate Endpoints for Patients
with IgA Nephropathy
Learn how endpoints from clinical trials inform patient
care
PLAY
care
Biomarkers in IgA Nephropathy
Explore the potential role for biomarkers in the
management of IgA nephropathy
management of IgA nephropathy
Beyond Kidney Function: Unlocking New Biomarkers in
IgA Nephropathy
Learn how existing and emerging
biomarkers have the potential to improve
outcomes for patients with IgA
nephropathy
biomarkers have the potential to improve
outcomes for patients with IgA
nephropathy
00:08:35
Biomarkers In-Depth
Take an in-depth look at the potential
role for biomarkers in the management
of IgA nephropathy
role for biomarkers in the management
of IgA nephropathy
00:27:35
References
1. McGrogan A, Franssen CFM, de Vries CS. The incidence of primary glomerulonephritis worldwide: a systematic review of the literature. Nephrology Dialysis Transplantation. 2011 Feb 1;26(2):414–30. 2. Pitcher D, Braddon F, Hendry B, Mercer A, Osmaston K, Saleem MA, et al. Long-Term Outcomes in IgA Nephropathy. Clinical Journal of the American Society of Nephrology. 2023 Apr 13;10.2215/CJN.0000000000000135.